Latest Breaking News On - Novel checkpoint - Page 1 : comparemela.com

/PRNewswire/ Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today.

United statesTel avivYvonne naughtonClinical development of novel checkpoint inhibitorsCompugen ltdStock exchangeCorporate communicationsPrnewswire compugen ltdAnnual meetingClinical developmentNovel checkpointDate thursdayNext generation checkpoint blockadeSouth san franciscoInvestor relationsCompugen ltd